Coping with behavioral and psychological challenges is part of the daily lives of many autistic adults. Consequently, there is great interest in finding ways to support their quality of life and improve their well-being. A new study published in Neuropsychopharmacol Rep, 2026 Sep, examined the effect of using medical cannabis products (CBMPs) on these measures.
The study, based on data from the UK Medical Cannabis Registry, followed 130 autistic adults treated with medical cannabis products. Researchers collected data at the start of treatment and over a period of up to 18 months, focusing primarily on measuring changes in anxiety levels, sleep quality, and overall quality of life as reported by the participants themselves.
Findings: Improvement in Various Measures
The findings indicate that over the 18-month follow-up period, significant improvements occurred in various measures. In particular, participants reported a marked reduction in anxiety levels and a significant improvement in sleep quality. In addition, an improvement was also observed in overall quality of life measures. It should be noted that during the study, 25 participants (approximately 19%) reported various side effects, the vast majority of which were classified as mild to moderate, indicating a reasonable safety profile but requiring monitoring.
What Does This Mean for Autistic Adults in Israel?
These findings suggest a possible link between the use of medical cannabis products and certain improvements in the quality of life, anxiety levels, and sleep quality of autistic adults. For autistic people in Israel, this information could be interesting and offer initial hope regarding future support options.
However, it is important to remember that this is an observational study, meaning it indicates correlations rather than proven causality. The absence of a control group in the current study is a significant limitation, as it does not allow for a definitive determination that the observed improvements are directly due to medical cannabis treatment and not to other factors that may have occurred simultaneously. To confirm the long-term efficacy and safety of this treatment among autistic people, rigorous additional research is needed, especially controlled and randomized clinical trials that can provide stronger evidence.